Mei Ri Jing Ji Xin Wen·2025-12-10 22:09Group 1: Economic Developments - The Federal Reserve announced a 25 basis point interest rate cut, lowering the target range to 3.5%-3.75%, marking the third consecutive cut since September 2023 and the sixth since the current easing cycle began in September 2024 [4] - The U.S. government reported a budget deficit of $173 billion for November, with total expenditures of $509 billion, down from $669 billion in November 2024, partly due to delayed payments from a recent government shutdown [5] - The International Monetary Fund (IMF) raised its forecast for China's economic growth in 2025 to 5.0%, an increase of 0.2 percentage points from its previous outlook [10] Group 2: Market Performance - Major U.S. stock indices closed higher, with the Dow Jones up 1.05%, Nasdaq up 0.33%, and S&P 500 up 0.68%. Notable gains were seen in large tech stocks, while some stocks like Meta and Microsoft experienced declines [5] - International oil prices rose, with WTI crude oil increasing by 1.25% to $58.98 per barrel and Brent crude oil up 1.18% to $62.67 per barrel [5] - Gold prices increased, with spot gold rising by 0.47% to $4,228 per ounce and COMEX gold futures up 0.51% to $4,257.8 per ounce [6] Group 3: Corporate Developments - Iron Construction Heavy Industry signed a technology cooperation agreement with Huawei to explore smart mining solutions, indicating a trend of traditional industries collaborating with tech giants for digital transformation [17] - Alibaba's Qwen3-TTS voice synthesis model received a comprehensive upgrade, enhancing its multilingual and multi-accent capabilities, reflecting significant advancements in AI technology [18] - SpaceX is reportedly planning an IPO with a target valuation of $1.5 trillion, which could become the largest IPO in history, surpassing Saudi Aramco's record [27] Group 4: Regulatory and Policy Changes - The National Medical Products Administration of China announced a shift in regulatory focus towards innovative products and domestic alternatives to critical technologies, aiming to support high-quality development in the pharmaceutical industry [9] - Starting January 1, 2026, China will ban the production of mercury-containing thermometers and blood pressure monitors, aligning with international environmental agreements [10]